OUR LATEST POST
CureVac exercises options in strategic collaboration with myNEO Therapeutics.
CureVac has exercised its options on a selected set of potential cancer vaccine targets identified by myNEO Therapeutics under the existing partnership agreement Two option fee payments triggered to myNEO Therapeutics By applying its AI-based ImmunoEngine platform,...
Innovating immunotherapies,
transforming tomorrow
Subscribe to our newsletter
Get the latest news & updates about myNEO Therapeutics
Home
About us
Products
Technology
Partners
Services
Contact
Quick links
Publications
Latest news
Privacy statement
Terms of use
Careers
Cookie statement
We use cookies to enhance your browsing experience and provide analytics. By continuing to use this website, you agree to our use of cookies. For more information, please read our privacy statement.
© 2023 - myNEO Therapeutics